Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized phase III study of denosumab before curettage for giant cell tumor of bone (JCOG1610, Preoperative Denosumab for GCTB RPIII)

Trial Profile

A randomized phase III study of denosumab before curettage for giant cell tumor of bone (JCOG1610, Preoperative Denosumab for GCTB RPIII)

Recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Oct 2018

At a glance

  • Drugs Denosumab (Primary)
  • Indications Bone cancer; Giant cell tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Oct 2018 According to the trial design data presented at the 43rd European Society for Medical Oncology Congress, the current enrollment is 3 patients in April 2018.
    • 23 Oct 2018 Trial design presented at the 43rd European Society for Medical Oncology Congress.
    • 10 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top